1. Home
  2. SBFM vs NDRA Comparison

SBFM vs NDRA Comparison

Compare SBFM & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.17

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

HOLD

Current Price

$3.51

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
NDRA
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
5.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
SBFM
NDRA
Price
$1.17
$3.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$30.00
AVG Volume (30 Days)
36.6K
27.5K
Earning Date
03-31-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,323,742.00
N/A
Revenue This Year
$10.26
N/A
Revenue Next Year
$32.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.24
N/A
52 Week Low
$1.15
$2.90
52 Week High
$3.90
$11.96

Technical Indicators

Market Signals
Indicator
SBFM
NDRA
Relative Strength Index (RSI) 37.93 34.60
Support Level $1.15 $3.48
Resistance Level $1.23 $3.78
Average True Range (ATR) 0.06 0.34
MACD 0.00 -0.02
Stochastic Oscillator 10.00 18.99

Price Performance

Historical Comparison
SBFM
NDRA

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: